AROG Pharmaceuticals, LLC Patent applications |
Patent application number | Title | Published |
20140088147 | METHOD OF INHIBITING MUTANT C-KIT - The present invention includes a method of reducing or inhibiting the kinase activity of C-KIT mutant tyrosine kinase activity in a cell or a subject, and the use of such compound for treating mutant C-KIT driven cell proliferative disorder(s) in a subject related to using a compound of the present invention: | 03-27-2014 |
20140088143 | Method of Inhibiting Constitutively Active Phosphorylated FLT3 Kinase - The present invention includes a method of inhibiting or reducing deregulated FLT3 tyrosine kinase activity or FLT3 tyrosine kinase expression in a subject with a proliferative disease by administering to the subject having or suspected to have the proliferative disease, a therapeutically or prophylactically effective amount of the compound of Formula I: | 03-27-2014 |